Carboplatin Injection
Avyxa Pharma, LLC · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 04/28/2023
- Package NDC
- 83831-141-08
- Generic name
- Carboplatin Injection
- Contact info
- 877-595-7337; customerservice@avyxa.com
- Availability
- Available
- Update date
- 09/01/2026
- Dosage form
- Injection
- Presentation
- Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)
- Company name
- Avyxa Pharma, LLC
- Status
- Current
- Therapeutic category
- Oncology
- Harmonized identifiers (openFDA)
- Application number
- NDA219921
- Brand name
- KYXATA
- Generic name
- CARBOPLATIN
- Manufacturer name
- Avyxa Pharma, LLC
- Product NDC
- 83831-141, 83831-140, 83831-142
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- CARBOPLATIN
- RxCUI
- 597195, 2721602
- SPL ID
- 5c711945-70be-42f4-b153-e1459dd9929c
- SPL set ID
- f91c48da-68d1-4aa7-89b8-d84a3e8b629b
- Package NDC
- 83831-140-02, 83831-141-08, 83831-142-50
- Nui
- N0000175413, N0000175073
- Pharm class epc
- Platinum-based Drug [EPC]
- UNII
- BG3F62OND5